Value Health Reg Issues. 2022; 29:16-20.
DOI of original article: https://doi.org/10.1016/j.vhri.2021.06.008
In the original article, the authors indicated that they combined the scores of each of Treatment Satisfaction Questionnaire for Medication’s (TSQM) 4 subscales (which are scored out of 100) to calculate a final score out of 400. Per the guideline of the organization, the TSQM was designed and validated originally to be reported as 4 separate scores only. It was not investigated using combined scores in the way the authors described in this paper.
The combined scores used in this paper were only one of the outcomes the authors investigated (ie, as a redundant measure for extra reassurance). While the authors regret this error, this error does not change the outcome of the study, its conclusions, or its recommendations.
Article info
Publication history
Published online: September 12, 2022
Identification
Copyright
© 2022 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Validating the “Treatment Satisfaction Questionnaire for Medication” in Persian and Evaluating Treatment Satisfaction Among Patients With PsoriasisValue in Health Regional IssuesVol. 29
- PreviewPsoriasis is a dermatological condition often associated with systemic comorbidities such as arthritis. Because of the vital role of treatment compliance in improvement in patients’ condition and the scarcity of studies on this subject in Iran, we decided to measure and compare treatment satisfaction (as a predictor of compliance) of patients with psoriasis by using the Treatment Satisfaction Questionnaire for Medication (TSQM).
- Full-Text
- Preview
